Explore the efficacy and safety concerns of Molnupiravir, an oral medication developed by Merck for mild to moderate COVID-19 cases, in this comprehensive 33-minute lecture. Delve into the drug's mechanism of action, pharmacology, intended population, and potential risks. Learn about the latest developments in COVID-19 treatment as Professor Zach Murphy presents detailed information supported by scientific references. Gain valuable insights into this innovative antiviral medication and its role in combating the ongoing pandemic.